›› 2020, Vol. 40 ›› Issue (1): 134-.doi: 10.3969/j.issn.1674-8115.2020.01.022

• Review • Previous Articles     Next Articles

Recent advances in using of stem cell-derived extracellular vesicles in treating central nervous system diseases

HE Zheng-hui, WANG Yang, DENG Zhi-feng   

  1. 1. School of Clinical Medicine, Shanghai Sixth Peoples Hospital, Shanghai Jiao Tong University, Shanghai 200233, China; 2.Institute of Microsurgery on Extremities, Shanghai Sixth Peoples Hospital, Shanghai Jiao Tong University, Shanghai 200233, China; 3. Department of Neurosurgery, Shanghai Sixth Peoples Hospital Shanghai Jiao Tong University, Shanghai 200233, China
  • Online:2020-01-28 Published:2020-03-05
  • Supported by:
    National Natural Science Foundation of China (81671209).

Abstract: Stem cell-derived extracellular vesicles can regulate functions of targeting cells in lesions and have fewer risks in treating diseases. In central nervous injury lesions, stem cell-derived extracellular vesicles can promote neurogenesis and angiogenesis and regulate nervous inflammation, which promotes the recovery of the nerve injury. Stem cell-derived extracellular vesicles can ease Aβ protein-related neuron damage in Alzheimers disease. Stem cell-derived extracellular vesicles also can deliver microRNA and chemotherapeutic agents to neuroglioma cells. This review introduces recent advances in using stem cell-derived extracellular vesicles in treating central nervous system diseases.

Key words: stem cell-derived extracellular vesicles (SC-EVs), central nervous system injury, Alzheimer’s disease, neuroglioma